Literature DB >> 4371529

Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. II. Effect of multiple doses of polyriboinosinic-polyribocytidylic acid on viral pathogenesis.

D A Stringfellow, J C Overall, L A Glasgow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4371529     DOI: 10.1093/infdis/130.5.481

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid.

Authors:  E R Kern; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

2.  Antiviral activity of bacteria-derived human alpha interferons against encephalomyocarditis virus infection of mice.

Authors:  P K Weck; E Rinderknecht; D A Estell; N Stebbing
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

3.  Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.

Authors:  G A Olsen; E R Kern; L A Glasgow; J C Overall
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

4.  Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.

Authors:  E R Kern; J R Hamilton; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

5.  Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice.

Authors:  D F Smee; J H Huffman; A C Gessaman; J W Huggins; R W Sidwell
Journal:  Antiviral Res       Date:  1991 Mar-Apr       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.